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A B S T R A C T  
Objective: To find out the association between dyslipidemias and ischemic and hemorrhagic stroke. 
Patients and Methods: This cross-sectional study was conducted in Medical Unit I, Jinnah Hospital Lahore (JHL) from 
1st January 2015 to 30th Jun 2015. A total of 420 cases of stroke were included via Nonprobability consecutive sampling 
technique. The sample size was calculated with 95% confidence level, 2% margin of error. At the time of admission, 
every patient underwent CT scan in the radiology department of JHL, fasting blood samples were taken, on next day of 
admission. Every sample was processed for lipid profile in pathology department of Allama Iqbal Medical College, 
(AIMC) Lahore. Based on CT scan findings, patients were labelled as ischemic or hemorrhagic stroke. Demographic 
details, BMI, blood pressure and Diabetic status were also recorded. 
Results: Out of 420 study participants, 47.6% (n=200) were male and 52.4% (n=220) were females, the mean age was 
39.29 + 11.82 years, mean BMI was 39.29 + 11.82 kg/m2. History of hypertension (HTN) was most frequent risk factor 
seen in 82.6% (n=347) followed by Diabetes mellitus (DM) 49.8% (n=209) and smoking found in 32.1% (n=135) cases. 
Frequency of Hypercholesterolemia (>200 mg/dl) was observed in 26.2% (n=110) and Hypertriglyceridemia (>150 mg/dl) 
in 7.9% (n=33) patients. High LDL (>130 mg/dl) levels were observed in 5.7% (n=24), high VLDL (>35 mg/dl) in 6.9% 
(n=29) patients, while low HDL (<35 mg/dl) was noticed in 17.1% (n=72) patients. There was significant association 
between type of stroke & hypercholesterolemia as well as low HDL levels (p-value<0.05). While insignificant association 
was found between type of stroke & hypertriglyceridemia and high VLDL (p-value>0.05). Effect modifiers i.e.; age, BMI, 
gender, history of smoking, HTN and DM were not significantly associated with type of stroke (p-value >0.05). 
Conclusion: Hypercholesterolemia & HDL levels are significantly associated with type of stroke, whereas serum 
hypertriglyceridemia, high LDL and high VLDL were not significantly associated with type of stroke. 
Key words: Dyslipidemia, Hemorrhagic stroke, Ischemic stroke, Stroke. 
Author`s Contribution 
1
 Conception, synthesis, planning of research 
and manuscript writing 
2 
Interpretation and discussion 
3
 Data analysis, interpretation and 
manuscript writing, 
4, 5 
Active participation in 
data collection  
Address of Correspondence 
Muhammad Saeed Aslam 
Email: m.saeed.aslam@gmail.com 
Article info. 
Received: Feb 23, 2017 
Accepted: August 9, 2017 
 
Cite this article. Aslam MS, Nasir KM, Hussain H,Saeed M,Walayt MS, Ahmad W,Shabbir 
MU. Pattern of Dyslipidemias and their Association with Ischemic and Hemorrhagic 
Stroke.JIMDC.2017;6(3):134-139 
 
 
Funding Source: Nil 
Conflict of Interest: Nil 
ORIGINAL ARTICLE 
                            135 JIMDC  2017  135 
I n t r o d u c t i o n  
Stroke is the commonest neurological cause of morbidity 
and mortality all over the world and the third leading 
cause of death. Evaluation of various risk factors for a 
population is not only helpful for identification of risk 
factors but this will be a great help for health care 
providers for management of these patients. 
Cerebrovascular accident is global health problem. A 
recent international survey has estimated about 15 million 
people worldwide suffer from nonfatal stroke annually and 
33% being permanently disabled.1 About 80% of all stroke 
deaths are registered in lower and middle-income 
countries.2 An estimated annual incidence of stroke in 
Pakistan is 250/100,000 with an estimate of 350,000 new 
cases every year.3,4 Stroke is a multifactorial disease; 
some of them are called primary, while the cause for 
others are uncertain and secondary. Among the latter, 
hyperlipidemia plays a significant role. As the acute stroke 
management is expensive and stroke itself is associated 
with significant morbidity and mortality, the saying that 
“prevention is better than cure” holds a special meaning 
here. It is apparent from different studies that stroke can 
be significantly reduced by taking measures for control of 
modifiable risk factors. The modifiable risk factors of 
stroke are similar to western population and comprise of 
hypertension, cardiac disease, diabetes mellitus and 
dyslipidemia. Hyperlipidemia causes hardening of the 
arteries with plaque formation and increases the risk of 
atherosclerosis.5 Lipids and other components of blood 
are the sources of plaque formation. Plaque formation is a 
cause of narrowing and hardness of blood vessels. As 
result, there is reduced blood flow, increasing the risk of 
stroke. Unfortunately, there are no symptoms for 
hyperlipidemia, and lipid profile in fasting is the only 
method to reveal lipid levels. The desired lipid levels 
include; total cholesterol levels < 200 mg/dl, low-density 
lipoprotein (LDL) also known as "bad cholesterol" should 
be < 130mg/dl, high-density lipoprotein (HDL) also called 
“good cholesterol" should be >40mg/dl and 50mg/dl for 
males and females respectively. Triglycerides levels 
should be <200 mg/dl.2 Once the person is diagnosed 
with hyperlipidemia, the next step is to consult a physician 
who may prescribe treatment or discuss lifestyle and diet 
plan depending upon the results.6  
As cholesterol levels increases, the risk of hemorrhagic 
stroke decreases and the risk of ischemic stroke 
increases. Stroke mortality is lowest at cholesterol levels 
between 180mg/dl and 200mg/dl. Mortality increases 
substantially above 240mg/dl. Mortality is highest from 
160mg/dl to 300mg/dl and above. Diet high in 
polyunsaturated fat and low in antioxidants can make 
LDL-cholesterol within the blood vulnerable to oxidation. 
Oxidized LDL can play a role in the development of 
stroke.7 Stroke, also known as cerebral vascular accident 
(CVA), is a second leading cause of death and disabilities 
around the globe.8 Alarming symptoms include numbness, 
weakness (often on one side), confusion, visual problems, 
slurred speech, trouble walking, dizziness, loss of balance 
loss of coordination and severe headache.9 There are two 
categories of stroke, ischemic & hemorrhagic, both are 
entirely conflicting to each other. Ischemic stroke is a 
most common entity, with numerous pathophysiologic 
mechanisms, results from blockage of a blood vessel 
supplying the brain, while the more damaging 
hemorrhagic stroke results from rupture of such a 
vessel.10 
Hypertension is another significant contributor to stroke, 
hypercholesterolemia may be an important factor leading 
to hypertension.11 Polyunsaturated fat and carbohydrates 
are associated with a higher risk of stroke. Exercise, 
stress management, proper control of oral or systemic 
infections, and adequate nutrition can lower the risk of 
stroke.12 Important protective nutrients include 
magnesium, potassium, antioxidants and adequate 
proteins. Modified lifestyle and timely medical 
management can treat hyperlipidemia, a major risk factor 
for stroke. Statins have been shown to decrease lipids 
and exert a pleiotropic effect on the intracranial 
vasculature and inflammatory modulators, leading to 
neuroprotection. Lower low-density lipoprotein and higher 
high-density lipoprotein levels are associated with 
decreased risk of stroke. Despite screening guidelines 
and evidence of the efficacy of statins, there are 
numerous barriers to maintaining adequate control of 
lipids.13 Therefore evaluation of Dyslipidemia is 
significantly important. The present study was planned to 
evaluate spectrum and association of hyperlipidemia 
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among patients presenting with ischemic & hemorrhagic 
stroke. 
P a t i e n t s  a n d  M e t h o d s  
This cross-sectional study was conducted at Medical Unit, 
Jinnah Hospital Lahore. During the period of six months 
from January 1 to June 30, 2015. All patients presenting 
with the acute first episode of stroke within one week of 
onset of symptoms were included while all of the following 
were excluded, i.e. (1) history of known secondary 
dyslipidemia, (2) Patients on lipid lowering therapy, (3) 
Patients with recurrent stroke or cerebrovascular accident 
(On history). A total of 420 stroke cases were included via 
non-probability consecutive sampling technique. At the 
time of admission, every patient was processed for CT 
scan in the radiology department of Jinnah hospital 
Lahore (JHL). Blood samples were taken by using aseptic 
measures and standard procedure after an 8 hour of over-
night fasting on next day of admission. Every sample was 
processed for lipid profile in pathology department 
(chemical pathology section) of Allama Iqbal Medical 
College, (AIMC) Lahore. Lipid abnormalities were labelled 
as Hypercholesterolemia (>200 mg/dl), 
Hypertriglyceridemia (>150 mg/dl), Increased Low-density 
lipoproteins (LDL) (>130 mg/dl), Increased very low-
density lipoproteins (VLDL) level (>35 mg/dl), decreased 
HDL (<35 mg/dl). Based on CT scan findings, patients 
were labelled as ischemic or hemorrhagic stroke as 
followed. 
Ischemic stroke: A stroke was labelled as the ischemic 
stroke if there was the presence of a hypodense area 
reported as ischemia on CT scan.                        
Hemorrhagic stroke: A stroke was labelled as 
hemorrhagic stroke in case of presence of a hyperdense 
area reported as hemorrhage on CT scan.                
Data Analysis: Numerical variables were analyzed as 
mean and SD. Frequency and percentage was calculated 
for categorical variables. Cross tabulation was done 
between abnormal lipid profile level and type of stroke.  
Data were stratified by age, gender, BMI, type of stroke, 
smoking, HTN and DM. Post-stratification Chi-square test 
was applied. A p-value < 0.05 was considered as 
statistically significant.  
 
R e s u l t s  
Out of 420 study participants, 47.6% (n=200) were male 
and 52.4% (n=220) were females. The mean age of the 
patients was 39.29 +11.82 years, mean BMI was 39.29 + 
11.82 kg/m2, mean cholesterol level was 171.45 + 32.7 
mg/dl, mean triglycerides level was 133.01 + 15.39 mg/dl, 
mean LDL level was 116.87 + 12.78 mg/dl, mean VLDL 
level was 21.88 + 10.93 mg/dl, mean HDL level was 
43.41 + 15.13 mg/dl. Patients suffering from ischemic and 
hemorrhagic stroke were 42% and 58% respectively 
(Figure1).  
 
Figure 1: Frequency distribution of strokes (n=420) 
Figure 2 represents frequency of different risk factors for 
stroke. As shown in the figure, history of hypertension 
was the most frequent risk factor seen in 82.6% (n=347) 
cases followed by diabetes mellitus in 49.8% (n=209) 
cases and smoking in 32.1% (n=135) cases.  
 
Figure 2: Frequency distribution of risk factor associated 
with stroke (n=420) 
Frequency of hypercholesterolemia was observed in 
26.2% (n=110) cases and hypertriglyceridemia was seen 
in 7.9% (n=33) cases. High LDL levels were observed in 
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5.7% (n=24), high VLDL in 6.9% (n=29) patients, while 
low HDL was noticed in 17.1% (n=72) patients (Figure 3).  
 
Figure 3: Frequency distribution of study participants with 
abnormal lipid profile (n=420) 
As shown in table 1, there was a significant association 
between type of stroke & hypercholesterolemia as well as 
low HDL levels (p-value<0.05). Other factors like age, 
BMI, gender, history of smoking, HTN and DM were not 
significantly associated with type of stroke (Table 2). 
 D i s c u s s i o n  
Stroke is a major public health problem that ranks in the 
top four causes of death in most countries. Dyslipidemias 
including high-density lipoproteins are the major risk factor 
for coronary heart disease, cerebrovascular disease, 
atherosclerosis, thrombosis, and stroke. The present 
study reported that females were more vulnerable to 
stroke as compared to males with earlier mean age of 
presentation (39.29 + 11.82 years) & mean BMI 
39.29+11.82 kg/m. However, majority of studies showed a 
male predominance in their studies with presentation at a 
later age. Bain LK et al, in their study reported that male 
suffered more than female with M:F ratio of 1.73:1 in 
ischemic group and 1.42:1 in Hemorrhagic group.11 
According to present study, hypercholesterolemia was 
observed in 26.2%, hypertriglyceridemia was noticed in 
7.9% (n=33) cases, high LDL levels were observed in 
5.7% (n=24), high VLDL in 6.9% (n=29) patients, while low  
HDL was noticed in 17.1% (n=72) patients. Our results 
are slightly different, but supported by the previous study 
Table :2 Association of Type of Stroke with other factors 
 Hemorrhagic Stroke 
n=178 
Ischemic Stroke 
n=242 
p-value 
Gender Male 79 121 0.255 
Female 99 121 
Age-Groups (Year) < 40 83 126 0.271 
> 40 95 116 
BMI (kg/m2) < 29 93 111 0.196 
> 29 85 131 
History of Smoking (n) Yes 48 87 0.051 
No 130 155 
History of hypertension (n) Yes 142 205 0.187 
No 36 37 
History of Diabetes mellitus (n)  Yes 89 120 0.933 
No 89 122 
Table 1: Association of Type of Stroke with Dyslipidemias 
Variable 
 
Results Hemorrhagic Stroke 
n=178 
Ischemic Stroke 
n=242 
p-value 
Hyper-cholesterolemia (n) Yes 26 84 0.000 
No 152 158 
Hyper-Triglyceridemia (n) Yes 9 24 0.097 
No 169 218 
High-LDL (n) Yes 9 15 0.676 
No 169 227 
High-VLDL (n) Yes 11 18 0.699 
No 167 224 
Low-HDL (n) Yes 10 62 0.000 
No 168 180 
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conducted on 100 patients of ischemic stroke patients. 
According to this study, the mean age of patients with 
stroke at presentation was 64.2±12 years with a male to 
female ratio of 3.6:1. They also reported that 
hypercholesterolemia was seen in 42.0%, 
hypertriglyceridemia in 4.0%, high LDL-cholesterol in 
5.0%, and VLDL-cholesterol in 7.0% patients. 
Low Serum HDL-cholesterol was observed in 31.0% 
cases of ischemic stroke. On the other hand, serum total 
cholesterol and triglycerides was raised in 05 patients 
each, LDL-cholesterol in 09 and VLDL-cholesterol in 03 
patients of hemorrhagic stroke. Serum HDL-cholesterol 
was below normal in 04 patients of hemorrhagic stroke. 
They also reported that there was a significantly greater 
number of patients with raised serum cholesterol and low 
HDL-cholesterol in ischemic stroke than hemorrhagic 
stroke (p < 0.05), the finding similar to our results.14 A 
greater number of patients in the recent study presented 
with ischemic stroke (58 %) while Hemorrhagic stroke 
was observed in (42.4%) cases. In one study among 540 
study participants (49.4% females) 19.1% (n=104) were 
observed to have a prior stroke while TIA was found in 
9.7% (n=53). History of smoking hypertension and 
diabetes mellitus were 32.1%, 82.6%, 49.8% 
respectively.13 Aquil mentioned that out of the 100 
patients with acute ischemic stroke, mean age at 
presentation was 63.5 years.15 
Risk factor distribution included hypertension 85.0%, 
diabetes mellitus 49.0%, ischemic heart disease 30.0%, 
dyslipidemia 22.0%, smoking 9.0%, atrial fibrillation 5.0%, 
and previous history of stroke in 29.0% cases. According 
to them, various subtypes of acute ischemic stroke were 
lacunar infarct seen in 43%, large artery atherosclerosis in 
31.0%, cardio embolic type in 8.0%, and stroke of 
undetermined etiology in 18.0% cases.15 Chaudhury 
reported that `fasting serum lipid profile analysis of 50 
ischemic stroke patients revealed raised serum total 
cholesterol in 42.0% patients with the mean serum 
cholesterol of 190±35mg/dl whereas only 5 patients 
among Hemorrhagic CVA showing raised serum 
cholesterol with the overall mean of 151±29mg/dl. Serum 
HDL was found to be low in 16 (32.0%) patients of 
Ischemic stroke with a mean value of 42.4±6mg/dl 
whereas only 6.0% of Hemorrhagic stroke patients 
showed low serum HDL with a mean value of 
45.4±5mg/dl. Abnormal serum triglyceride level was 
found to be distributed similarly in Ischemic & 
Hemorrhagic stroke with the mean value of 137±30mg/dl 
& 125±30mg/dl respectively. High serum LDL was found 
in 6.0% & 4.0% of ischemic & Hemorrhagic stroke with 
mean value of 102±21mg/dl & 93±17mg/dl respectively. 
Hypercholesterolemia and low HDL-cholesterol was seen 
significantly more in ischemic CVA group as compared to 
those with hemorrhagic disease.16 Mahmood et al from 
Pakistan also reported that there were significantly 
greater number of patients with raised serum cholesterol 
and low HDL-cholesterol in ischemic stroke than 
Hemorrhagic stroke (p < 0.05). No statistical significance 
was found on comparing serum values of ischemic and 
Hemorrhagic stroke for triglycerides, LDL-cholesterol and 
VLDL-cholesterol. Ischemic stroke patients had high 
serum total cholesterol and lower HDL-cholesterol levels 
as compared to hemorrhagic stroke.14 According to Zhang  
et al, factors which are significantly associated with 
ischemic stroke as opposed to hemorrhagic stroke were 
family history of stroke, obesity, atherosclerotic plaque of 
the common carotid artery, atrial fibrillation, 
hyperfibrinogenemia, transient ischemic attack (TIA), 
atherosclerotic plaque of the internal carotid artery, 
coronary heart, lower high-density lipoproteins (lower 
HDL), increasing age, diabetes mellitus, and male gender. 
Hypertension and family history of hypertension were the 
significant factors associated with hemorrhagic stroke 
versus ischemic stroke. Smoking, alcohol intake, kidney 
diseases and lower HDL-C were the significant factors 
contributing to ischemic stroke in man. Obesity, family 
history of hypertension, family history of stroke, 
hypercholesteremia and myocardial ischemia were the 
significant factors for females with ischemic stroke.17 
Osama A et al in their study, conducted on patterns of 
dyslipidemias in patients of ischemic stroke reported that 
high LDL and lipoprotein A were more frequent finding in 
ischemic stroke than other patterns of dyslipidemia.18 In 
their study, they observed that hypertension was the most 
frequent risk factor (74.3%) followed by 
hyperglycemia(64%) then dyslipidemia (57.1%) then 
smoking (53.3%), and these results are almost 
comparable with our results. However, they also reported 
that prevalence of dyslipidemia in males was 68.4%, 
which was significantly higher than in females (43.8%), 
and according to them prevalence of dyslipidemia was 
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more in the age group>65 years (63.2%) than in the age 
group≤ 65 years (53.7%), the findings are not comparable 
with our results. One of the local study conducted by 
Khan et al reported, that of 55 patients of ischemic stroke 
studied, 78% were males and 22% were females, the 
finding not comparable with our results. They also 
reported that hypertension (65%), dyslipidemia (32.7%), 
diabetes mellitus (36.3%) and smoking was found in 32% 
cases of ischemic stroke patients. (18) Meta-analysis of 
some studies shows that higher the level of total 
cholesterol (TC), greater the risk of CVA and higher the 
high-density lipoprotein cholesterol (HDLC), lower the risk 
and each being an independent risk factor. Moreover, TC 
to HDL ratio is better predictor of ischemic CVA and is 
considered a useful clinical tool. The contribution of 
various risk factors for stroke may be different in different 
ethnicities.19 
C o n c l u s i o n  
Ischemic stroke was more frequent as compared to 
hemorrhagic stroke. Serum total cholesterol level and 
serum HDL level were significantly associated with a type 
of stroke whereas serum triglyceride level, serum LDL, 
and serum VLDL did not have significant association with 
type of stroke. 
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